1. Medicamen Biotech
stock logo

Medicamen Biotech Share Price

MEDICAMEQ

₹479.80-₹5.25 (-1.08%) TodayLast updated on 21 Jun, 2024 | 03:29 PM IST
₹477.15₹489.85
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹609 Crs

Open

₹489.85

Close

₹485.05

Circuit range

₹574.85 - ₹383.25

Day range

₹477.15 - ₹489.85

Year range

₹355.45 - ₹845.00

Volume

5,537

Avg. traded

₹480.56

Revenue (12m)

₹179 Crs

Medicamen BiotechMedicamen Biotech Limited is an India-based integrated pharmaceutical and life sciences solution provider company. The Company is engaged in manufacturing of diverse range of pharmaceutical products oral solids, oral liquids, ointment for non-oncology products range and also produces tablets, capsule/lyohilized/dry powder injections for oncology product range. It focuses on oncology therapeutics, and other generics. The Company manufactures a range of products, including tablets, capsules, liquid syrup, dry syrup, such as beta-lactum and non-beta lactum, and ointments. The Company primarily focuses on oncology therapeutics. It is also focused on other therapeutic areas, such as cardiology, central nervous system (CNS), diabetology and pain management. Its oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, Bortezomib, Busulfan, Capecitabine, Cisplatin, Erlotinib HCL, Gefitinib, Imatinib mesylate, Lenalidomide, Letrozole, Melphalan, and Pazopanib.

Medicamen Biotech Key indicators

arrow

52 week high

₹845.00

52 week low

₹355.45

P/E ratio

59.09

P/B ratio

3.15

ROE

9.17%

ROCE

10.95%

Dividend yield

0.21%

Debt/Equity ratio

0.14

EPS

11.86

Learn more

Investment checklist: (1/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

19.64%

Net profit margin

10.88%

ROE

9.17%

ROA

6%

ROCE

10.95%

Learn more

Medicamen Biotech Shareholder returns

arrow

1 day

-1.24%

1 week

+0.74%

1 month

-6.70%

3 months

+17.98%

1 year

-29.93%

3 years

-13.22%

5 years

-13.22%

Medicamen Biotech Share Price history

arrow
DayOpenCloseDay’s change
Fri, Jun 21 2024
₹489.85
₹479.05
-1.24%
Thu, Jun 20 2024
₹472.50
₹485.05
+3.19%
Wed, Jun 19 2024
₹473.00
₹470.05
-0.11%
Tue, Jun 18 2024
₹480.00
₹470.55
-1.84%
Fri, Jun 14 2024
₹476.95
₹479.35
+0.80%
Thu, Jun 13 2024
₹482.00
₹475.55
-0.82%
Wed, Jun 12 2024
₹482.10
₹479.50
-0.54%
Tue, Jun 11 2024
₹484.95
₹482.10
+1.45%

Shareholding info

arrow

Promoters (43.21%)

Mutual Funds (0%)

Retail and other (55.69%)

Foreign institutions-FII (0.12%)

Other domestic institutions (0.98%)

Retail and other

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹1/share

    Ex date 20 Sep 2023

    expand tab
  • Dividend • ₹1/share

    Ex date 19 Sep 2022

    expand tab

Learn more

Frequently asked questions